Area of research
Oncology · Cancer Research
Research interest
Research focused on Bioavailability and Hepatocellular carcinoma, with related work in Immunotherapy, Antibiosis, Stem cell. Notable publications include 'Retracted: Global microarray profiling identified hsa_circ_0064428 as a potential immune-associated prognosis biomarker for hepatocellular carcinoma', '3D‐Printed Dendritic Cell Vaccines for Post‐Surgery Cancer Immunotherapy', and 'The applications of 3D printing in wound healing: The external delivery of stem cells and antibiosis'.
Finotonlimab (PD-1 inhibitor) plus bevacizumab (bevacizumab biosimilar) as first-tier therapy for late-stage hepatocellular carcinoma: a randomized phase 2/3 trial
3D‐Printed Dendritic Cell Vaccines for Post‐Surgery Cancer Immunotherapy
Platelet Membrane‐Coated Curcumin‐PLGA Nanoparticles Promote Astrocyte‐Neuron Transdifferentiation for Intracerebral Hemorrhage Treatment
Anti-inflammatory oligosaccharide licensed mesenchymal stem cells allow prolonged survival of septic rats via the promotion of glutathione synthesis
Lycium barbarum oligosaccharide-derived carbon quantum dots inhibit glial scar formation while promoting neuronal differentiation of neural stem cells
The applications of 3D printing in wound healing: The external delivery of stem cells and antibiosis
3MO First-line camrelizumab plus carboplatin and paclitaxel for advanced squamous non-small cell lung cancer: Updated overall survival results from the phase III CameL-sq trial
Preparation of Pinocembrin-Loaded F127/MPEG-PDLLA Polymer Micelles and Anti-Osteoporotic Activity
Preparation, In Vivo and In Vitro Evaluation, and Pharmacodynamic Study of DMY‐Loaded Self‐Microemulsifying Drug Delivery System
Retracted: Global microarray profiling identified <i>hsa_circ_0064428</i> as a potential immune-associated prognosis biomarker for hepatocellular carcinoma